BHARAT PARENTERALS LTD. (BPLPHARMA) financials

BHARAT PARENTERALS LTD. (BPLPHARMA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations[1]

Market Cap: ₹1,282Cr.
Current Price: ₹1,860
Stock P/E: 132
ROE: 4.00%
ROCE: 5.75%
Book Value: ₹584
Dividend Yield: 0.05%
52W High / Low: ₹2,278/880

In Jun 2026, BHARAT PARENTERALS LTD. (BPLPHARMA) reported sales ₹55.50 Cr and net profit ₹3.66 Cr.

Annual TTM: sales ₹195 Cr, net profit ₹10 Cr.

Shareholding: Promoters 67.20% (Jun 2026), FIIs 0.11% (Jun 2026), DIIs 1.38% (Jun 2026), Public 31.31% (Jun 2026), No. of Shareholders 3,059% (Jun 2026).

BPLPHARMA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	64.45	67.34	80.28	94.37	41.70	41.41	56.54	55.50
Expenses	58.79	58.99	75.68	79.11	39.36	37.94	56.51	48.67
Operating Profit	5.66	8.35	4.60	15.26	2.34	3.47	0.03	6.83
OPM %	8.78%	12.40%	5.73%	16.17%	5.61%	8.38%	0.05%	12.31%
Other Income	4.60	3.79	2.26	1.62	4.21	2.28	4.44	1.05
Interest	0.88	1.41	1.48	1.42	0.96	0.55	0.51	0.69
Depreciation	1.75	1.86	1.82	2.06	2.17	2.10	2.04	2.26
Profit before tax	7.63	8.87	3.56	13.40	3.42	3.10	1.92	4.93
Tax %	28.05%	26.61%	35.96%	25.37%	20.18%	38.06%	28.65%	25.96%
Net Profit	5.49	6.50	2.28	10.00	2.73	1.92	1.38	3.66
EPS in Rs	8.41	9.43	3.31	14.51	3.96	2.79	2.00	5.31
Raw PDF	—	—	—	—	—	—	—	—

BPLPHARMA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	226	204	212	218	258	304	234	195
Expenses	196	179	183	196	225	269	213	182
Operating Profit	30	25	29	22	33	35	21	13
OPM %	13%	12%	14%	10%	13%	11%	9%	6%
Other Income	11	9	7	19	8	14	13	12
Interest	1	1	1	3	4	5	3	3
Depreciation	6	6	7	6	6	7	8	9
Profit before tax	35	27	28	32	31	36	22	13
Tax %	25%	25%	25%	24%	27%	27%	27%	—
Net Profit	26	20	21	24	23	26	16	10
EPS in Rs	45.90	35.27	36.89	42.15	38.82	38.38	23.24	14.06
Dividend Payout %	0%	0%	0%	2%	3%	3%	4%	—

BPLPHARMA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	6	6	6	7	7
Reserves	91	117	138	160	185	208	380	395
Borrowings	5	1	12	15	46	83	65	20
Other Liabilities	60	68	40	37	71	91	98	98
Total Liabilities	161	192	196	218	308	387	549	520
Fixed Assets	35	33	45	41	36	39	46	51
CWIP	1	12	0	1	0	0	5	6
Investments	2	0	42	16	38	49	168	195
Other Assets	123	147	110	160	233	299	330	269
Total Assets	161	192	196	218	308	387	549	520

BPLPHARMA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	20	14	30	-22	-12	-0	19	45
Cash from Investing Activity	-9	-13	-46	22	-14	-38	-90	4
Cash from Financing Activity	-4	-3	8	2	29	34	69	-49
Net Cash Flow	7	-1	-8	2	3	-5	-1	-0
Free Cash Flow	11	-0	24	-27	-7	-10	-1	30
CFO/OP	102%	81%	145%	-56%	-13%	28%	85%	250%

BPLPHARMA shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	65.35%	67.20%	67.20%	67.19%	67.19%	67.19%	67.17%	67.20%
FIIs	0.08%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%	0.11%
DIIs	0.57%	0.54%	0.54%	0.54%	0.54%	0.54%	1.07%	1.38%
Public	33.98%	32.16%	32.15%	32.16%	32.16%	32.17%	31.65%	31.31%
No. of Shareholders	2,748	3,116	3,177	3,231	3,205	3,172	3,095	3,059

BPLPHARMA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	109	132	122	126	188	198	198	188
Inventory Days	55	69	61	56	100	125	90	131
Days Payable	82	106	71	60	127	121	121	97
Cash Conversion Cycle	82	95	111	122	161	202	167	222
Working Capital Days	78	97	111	150	98	68	97	172
ROCE %	40%	32%	20%	18%	14%	13%	11%	6%

BPLPHARMAUpdated 30 Sept 2026, 11:32

Bharat Parenterals Ltd.

BPLPHARMAUpdated 30 Sept 2026, 11:32

Market Cap

₹1,282Cr.

Current Price

₹1,860

High / Low

₹2,278/880

Stock P/E

132

ROE4.00%

ROCE5.75%

Book Value₹584

Face Value₹10.0

Dividend Yield0.05%

About

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	69.91	0.88	58.42	2.86	1.51	11.96	25.67	8.89	15.39
Sep 2023	59.81	0.61	53.38	3.46	1.61	7.67	27.51	5.56	9.55
Dec 2023	58.8	0.61	52.02	2.4	1.67	6.9	26.52	5.07	8.71
Mar 2024	65.64	1.09	61.91	3.24	1.61	4.27	28.1	3.07	5.28
Jun 2024	92.06	1.02	77.07	3.9	1.61	16.26	25.09	12.18	18.67
Sep 2024	64.45	0.88	58.79	4.6	1.75	7.63	28.05	5.49	8.41
Dec 2024	67.34	1.41	58.99	3.79	1.86	8.87	26.61	6.5	9.43
Mar 2025	80.28	1.48	75.68	2.26	1.82	3.56	35.96	2.28	3.31
Jun 2025	94.37	1.42	79.11	1.62	2.06	13.4	25.37	10	14.51
Sep 2025	41.7	0.96	39.36	4.21	2.17	3.42	20.18	2.73	3.96
Dec 2025	41.41	0.55	37.94	2.28	2.1	3.1	38.06	1.92	2.79
Mar 2026	56.54	0.51	56.51	4.44	2.04	1.92	28.65	1.38	2
Jun 2026	55.5	0.69	48.67	1.05	2.26	4.93	25.96	3.66	5.31

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	119	2	108	4	4	9	15	7	12.98
Mar 2016	125	1	114	5	4	9	31	6	11.26
Mar 2017	111	1	104	8	6	8	7	7	12.88
Mar 2018	136	1	123	7	6	14	27	10	17.63
Mar 2019	220	1	189	13	6	36	37	23	39.39
Mar 2020	226	1	196	11	6	35	25	26	45.9
Mar 2021	204	1	179	9	6	27	25	20	35.27
Mar 2022	212	1	183	7	7	28	25	21	36.89
Mar 2023	218	3	196	19	6	32	24	24	42.15
Mar 2024	258	4	225	8	6	31	27	23	38.82
Mar 2025	304	5	269	14	7	36	27	26	38.38
Mar 2026	234	3	213	13	8	22	27	16	23.24
TTM	195	3	182	12	9	13	—	10	14.06

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	67.2%
FIIs	0.11%
DIIs	1.38%
Public	31.31%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	73.84%	0%	0.01%	26.15%
Dec 2023	73.84%	0%	0.01%	26.15%
Mar 2024	73.27%	0%	0.01%	26.72%
Jun 2024	73.27%	0%	0.01%	26.72%
Sep 2024	65.35%	0.08%	0.57%	33.98%
Dec 2024	67.2%	0.11%	0.54%	32.16%
Mar 2025	67.2%	0.11%	0.54%	32.15%
Jun 2025	67.19%	0.11%	0.54%	32.16%
Sep 2025	67.19%	0.11%	0.54%	32.16%
Dec 2025	67.19%	0.11%	0.54%	32.17%
Mar 2026	67.17%	0.11%	1.07%	31.65%
Jun 2026	67.2%	0.11%	1.38%	31.31%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	6	44	16	50	116	29	0	0	87	116
Mar 2016	6	51	19	44	120	35	0	0	85	120
Mar 2017	6	58	6	40	111	31	0	1	79	111
Mar 2018	6	69	9	50	133	34	0	1	99	133
Mar 2019	6	91	5	60	161	35	1	2	123	161
Mar 2020	6	117	1	68	192	33	12	0	147	192
Mar 2021	6	138	12	40	196	45	0	42	110	196
Mar 2022	6	160	15	37	218	41	1	16	160	218
Mar 2023	6	185	46	71	308	36	0	38	233	308
Mar 2024	6	208	83	91	387	39	0	49	299	387
Mar 2025	7	380	65	98	549	46	5	168	330	549
Mar 2026	7	395	20	98	520	51	6	195	269	520

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0	0	0	0
Mar 2016	—	—	—	—
Mar 2017	-2	-2	-8	-11
Mar 2018	6	-8	4	2
Mar 2019	20	-9	-4	7
Mar 2020	14	-13	-3	-1
Mar 2021	30	-46	8	-8
Mar 2022	-22	22	2	2
Mar 2023	-12	-14	29	3
Mar 2024	0	-38	34	-5
Mar 2025	19	-90	69	-1
Mar 2026	45	4	-49	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	179	129	144	158	109	132	122	126	188	198	198	188
Inventory Days	55	62	69	60	55	69	61	56	100	125	90	131
Days Payable	188	171	167	110	82	106	71	60	127	121	121	97
Cash Conversion Cycle	47	20	46	108	82	95	111	122	161	202	167	222
Working Capital Days	58	8	65	82	78	97	111	150	98	68	97	172
ROCE %	17%	15%	12%	19%	40%	32%	20%	18%	14%	13%	11%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BHARAT PARENTERALS LTD. (BPLPHARMA)?

The reported market capitalisation for BHARAT PARENTERALS LTD. (BPLPHARMA) is ₹1,282Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BPLPHARMA?

The current price shown for BHARAT PARENTERALS LTD. (BPLPHARMA) on Fincrux is ₹1,860 with a 52-week high/low of ₹2,278/880.

What is the P/E ratio of BHARAT PARENTERALS LTD. (BPLPHARMA)?

The stock P/E for BHARAT PARENTERALS LTD. (BPLPHARMA) is 132 on Fincrux, with ROE at 4.00% and ROCE at 5.75%.

What were BPLPHARMA latest quarterly results?

For Jun 2026, BHARAT PARENTERALS LTD. (BPLPHARMA) reported sales ₹55.50 Cr and net profit ₹3.66 Cr (figures in ₹ crore unless noted).

What are BPLPHARMA annual sales and net profit?

For TTM, BHARAT PARENTERALS LTD. (BPLPHARMA) shows sales of ₹195 Cr and net profit of ₹10 Cr on the Fincrux profit & loss statement.

Who owns BHARAT PARENTERALS LTD. (BPLPHARMA)?

Latest shareholding for BHARAT PARENTERALS LTD. (BPLPHARMA) on Fincrux: Promoters 67.20% (Jun 2026), FIIs 0.11% (Jun 2026), DIIs 1.38% (Jun 2026), Public 31.31% (Jun 2026), No. of Shareholders 3,059% (Jun 2026).

Where can I find BHARAT PARENTERALS LTD. (BPLPHARMA) financials?

BHARAT PARENTERALS LTD. (BPLPHARMA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BPLPHARMA balance sheet and cash flow?

Yes. The BHARAT PARENTERALS LTD. (BPLPHARMA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 30 September 2026 at 11:32